REBINYN®, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for:
• On-demand treatment and control of bleeding episodes
• Perioperative management of bleeding
Limitations of Use:
REBINYN® is not indicated for routine prophylaxis in the treatment of patients with hemophilia B. REBINYN® is not indicated for immune tolerance induction in patients with hemophilia B.
For full prescribing, dosing and other information, please refer to the prescribing information linked below.